-
Something wrong with this record ?
Toward 3D dose verification of an electronic brachytherapy source with a plastic scintillation detector
P. Georgi, G. Kertzscher, L. Nyvang, J. Šolc, T. Schneider, K. Tanderup, JG. Johansen
Language English Country United States
Document type Journal Article
Grant support
18NRM02 PRISM-eBT
EMPIR from Participating States and from the European Union's Horizon 2020 research and innovation Programme
NNF19OC0058756
Novo Nordisk Fonden
PubMed
35196404
DOI
10.1002/mp.15568
Knihovny.cz E-resources
- MeSH
- Brachytherapy * MeSH
- Electronics MeSH
- Monte Carlo Method MeSH
- Plastics MeSH
- Radiometry MeSH
- Water MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Electronic brachytherapy (eBT) is considered a safe treatment with good outcomes. However, eBT lacks standardized and independent dose verification, which could impede future use. PURPOSE: To validate the 3D dose-to-water distribution of an electronic brachytherapy (eBT) source using a small-volume plastic scintillation detector (PSD). METHODS: The relative dose distribution of a Papillon 50 (P50) (Ariane Medical Systems, UK) eBT source was measured in water with a PSD consisting of a cylindrical scintillating BCF-12 fiber (length: 0.5 mm, Ø: 1 mm) coupled to a photodetector via an optical fiber. The measurements were performed with the PSD mounted on a motorized stage in a water phantom (MP3) (PTW, Germany). This allowed the sensitive volume of the PSD to be moved to predetermined positions relative to the P50 applicator, which pointed vertically downward while just breaching the water surface. The percentage depth-dose (PDD) was measured from 0 to 50 mm source-to-detector distance (SDD) in 1-3 mm steps. Dose profiles were measured along two perpendicular axes at five different SDDs with step sizes down to 0.5 mm. Characterization of the PSD consisted of determining the energy correction through Monte Carlo (MC) simulation and by measuring the stability and dose rate linearity using a well-type ionization chamber as a reference. The measured PDD and profiles were validated with corresponding MC simulations. RESULTS: The measured and simulated PDD curves agreed within 2% (except at 0 mm and 43 mm depth) after the PSD measurements were corrected for energy dependency. The absorbed dose decreased by a factor of 2 at 7 mm depth and by a factor of 10 at 26 mm depth. The measured dose profiles showed dose gradients at the profile edges of more than 50%/mm at 5 mm depth and 15%/mm at 50 mm depth. The measured profile widths increased 0.66 mm per 1 mm depth, while the simulated profile widths increased 0.74 mm per 1 mm depth. An azimuthal dependency of > 10% was observed in the dose at 10 mm distance from the beam center. The total uncertainty of the measured relative dose is < 2.5% with a positional uncertainty of 0.4 mm. The measurements for a full 3D dose characterization (PDD and profiles) can be carried out within 8 h, the limiting factor being cooling of the P50. CONCLUSION: The PSD and MP3 water phantoms provided a method to independently verify the relative 3D dose distribution in water of an eBT source.
Department of Clinical Medicine Aarhus University Aarhus Denmark
Department of Oncology Aarhus University Hospital Aarhus N Denmark
Photon Dosimetry Laboratory Czech Metrology Institute Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018626
- 003
- CZ-PrNML
- 005
- 20220804134921.0
- 007
- ta
- 008
- 220720s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mp.15568 $2 doi
- 035 __
- $a (PubMed)35196404
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Georgi, Peter $u Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
- 245 10
- $a Toward 3D dose verification of an electronic brachytherapy source with a plastic scintillation detector / $c P. Georgi, G. Kertzscher, L. Nyvang, J. Šolc, T. Schneider, K. Tanderup, JG. Johansen
- 520 9_
- $a BACKGROUND: Electronic brachytherapy (eBT) is considered a safe treatment with good outcomes. However, eBT lacks standardized and independent dose verification, which could impede future use. PURPOSE: To validate the 3D dose-to-water distribution of an electronic brachytherapy (eBT) source using a small-volume plastic scintillation detector (PSD). METHODS: The relative dose distribution of a Papillon 50 (P50) (Ariane Medical Systems, UK) eBT source was measured in water with a PSD consisting of a cylindrical scintillating BCF-12 fiber (length: 0.5 mm, Ø: 1 mm) coupled to a photodetector via an optical fiber. The measurements were performed with the PSD mounted on a motorized stage in a water phantom (MP3) (PTW, Germany). This allowed the sensitive volume of the PSD to be moved to predetermined positions relative to the P50 applicator, which pointed vertically downward while just breaching the water surface. The percentage depth-dose (PDD) was measured from 0 to 50 mm source-to-detector distance (SDD) in 1-3 mm steps. Dose profiles were measured along two perpendicular axes at five different SDDs with step sizes down to 0.5 mm. Characterization of the PSD consisted of determining the energy correction through Monte Carlo (MC) simulation and by measuring the stability and dose rate linearity using a well-type ionization chamber as a reference. The measured PDD and profiles were validated with corresponding MC simulations. RESULTS: The measured and simulated PDD curves agreed within 2% (except at 0 mm and 43 mm depth) after the PSD measurements were corrected for energy dependency. The absorbed dose decreased by a factor of 2 at 7 mm depth and by a factor of 10 at 26 mm depth. The measured dose profiles showed dose gradients at the profile edges of more than 50%/mm at 5 mm depth and 15%/mm at 50 mm depth. The measured profile widths increased 0.66 mm per 1 mm depth, while the simulated profile widths increased 0.74 mm per 1 mm depth. An azimuthal dependency of > 10% was observed in the dose at 10 mm distance from the beam center. The total uncertainty of the measured relative dose is < 2.5% with a positional uncertainty of 0.4 mm. The measurements for a full 3D dose characterization (PDD and profiles) can be carried out within 8 h, the limiting factor being cooling of the P50. CONCLUSION: The PSD and MP3 water phantoms provided a method to independently verify the relative 3D dose distribution in water of an eBT source.
- 650 12
- $a brachyterapie $7 D001918
- 650 _2
- $a elektronika $7 D004581
- 650 _2
- $a metoda Monte Carlo $7 D009010
- 650 _2
- $a plastické hmoty $7 D010969
- 650 _2
- $a radiometrie $7 D011874
- 650 _2
- $a voda $7 D014867
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kertzscher, Gustavo $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
- 700 1_
- $a Nyvang, Lars $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
- 700 1_
- $a Šolc, Jaroslav $u Photon Dosimetry Laboratory, Czech Metrology Institute, Prague, Czech Republic
- 700 1_
- $a Schneider, Thorsten $u Division for Ionizing Radiation, WG 6.34 "Dosimetry for Brachytherapy and Beta Radiation Protection", Physicalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
- 700 1_
- $a Tanderup, Kari $u Department of Clinical Medicine, Aarhus University, Aarhus, Denmark $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
- 700 1_
- $a Johansen, Jacob Graversen $u Department of Clinical Medicine, Aarhus University, Aarhus, Denmark $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
- 773 0_
- $w MED00003245 $t Medical physics $x 2473-4209 $g Roč. 49, č. 5 (2022), s. 3432-3443
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35196404 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134915 $b ABA008
- 999 __
- $a ok $b bmc $g 1822305 $s 1169869
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 49 $c 5 $d 3432-3443 $e 20220303 $i 2473-4209 $m Medical physics $n Med Phys $x MED00003245
- GRA __
- $a 18NRM02 PRISM-eBT $p EMPIR from Participating States and from the European Union's Horizon 2020 research and innovation Programme
- GRA __
- $a NNF19OC0058756 $p Novo Nordisk Fonden
- LZP __
- $a Pubmed-20220720